Afya (NASDAQ:AFYA - Get Free Report) is projected to post its Q1 2025 quarterly earnings results before the market opens on Thursday, May 8th. Analysts expect the company to announce earnings of $0.46 per share and revenue of $923.11 million for the quarter.
Afya Price Performance
Shares of NASDAQ:AFYA traded down $0.26 on Friday, hitting $19.12. The company had a trading volume of 123,518 shares, compared to its average volume of 122,972. The company has a market cap of $1.79 billion, a PE ratio of 15.42, a PEG ratio of 0.29 and a beta of 0.66. The business has a 50 day moving average of $17.69 and a 200 day moving average of $16.81. Afya has a 52-week low of $14.52 and a 52-week high of $20.06. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.51.
Afya Announces Dividend
The company also recently announced a -- dividend, which was paid on Friday, April 4th. Shareholders of record on Wednesday, March 26th were paid a $0.232 dividend. The ex-dividend date was Wednesday, March 26th. Afya's payout ratio is currently 17.69%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the company. Morgan Stanley downgraded Afya from an "equal weight" rating to an "underweight" rating and lowered their price objective for the company from $19.00 to $17.00 in a research report on Tuesday, March 11th. JPMorgan Chase & Co. dropped their price objective on shares of Afya from $25.00 to $20.50 and set a "neutral" rating for the company in a research note on Friday, January 17th. Finally, Citigroup restated a "sell" rating and set a $15.00 price objective (down from $18.00) on shares of Afya in a report on Friday, January 31st. Three investment analysts have rated the stock with a sell rating and two have given a hold rating to the company's stock. According to data from MarketBeat, Afya presently has a consensus rating of "Reduce" and a consensus price target of $17.60.
Read Our Latest Stock Analysis on AFYA
Afya Company Profile
(
Get Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Stories

Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.